UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Cognitive Aspects of Response to Treatment for Weight-related Health to Improve Eating and Exercise Earlier in Life

Not Applicable

Completed

Conditions: Executive Function
Pediatric Obesity

Interventions: Behavioral: Family-based Behavioral Treatment (FBT)

First Posted Date: 2017-11-01

Last Posted Date: 2023-11-07

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 34

Registration Number: NCT03329300

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer

Phase 1

Withdrawn

Conditions: Non-melanoma Skin Cancer

Interventions: Drug: UAB30
Drug: Placebo

First Posted Date: 2017-10-31

Last Posted Date: 2024-08-07

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT03327064

Locations: 🇺🇸
UAB Dermatology, Birmingham, Alabama, United States

Positron Emission Tomography (PET) Imaging with Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness

Early Phase 1

Recruiting

Conditions: Breast Cancer

Interventions: Drug: [89Zr]-Df-Trastuzumab
Diagnostic Test: PET/MRI Imaging

First Posted Date: 2017-10-25

Last Posted Date: 2025-01-27

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 10

Registration Number: NCT03321045

Locations: 🇺🇸
The Kirklin Clinic, Birmingham, Alabama, United States

Exercise and Learning and Memory in Multiple Sclerosis

Not Applicable

Terminated

Conditions: Multiple Sclerosis
Memory Impairment
Cognitive Change
Physical Activity

Interventions: Behavioral: Treadmill Walking Exercise Training
Behavioral: Stretching-and-toning Exercise Training

First Posted Date: 2017-10-24

Last Posted Date: 2021-10-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 14

Registration Number: NCT03319771

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer

Early Phase 1

Completed

Conditions: Locally Advanced Head and Neck Cancer

Interventions: Drug: Xtampza ER

First Posted Date: 2017-10-23

Last Posted Date: 2021-07-20

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 28

Registration Number: NCT03317730

Locations: 🇺🇸
Hazelrig-Salter Radiation Oncology Center, Birmingham, Alabama, United States

CONfident Treatment Decisions in Living With Rheumatoid Arthritis

Not Applicable

Completed

Conditions: Rheumatoid Arthritis

Interventions: Other: Patient Control
Other: Patient Educational Intervention

First Posted Date: 2017-10-23

Last Posted Date: 2021-09-02

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 208

Registration Number: NCT03317756

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease

Not Applicable

Active, not recruiting

Conditions: Essential Tremor
Parkinson Disease

Interventions: Device: Unframed Virtual Cone

First Posted Date: 2017-10-10

Last Posted Date: 2024-10-28

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 40

Registration Number: NCT03305588

Locations: 🇺🇸
University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center, Birmingham, Alabama, United States

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

Phase 2

Terminated

Conditions: Hepatocellular Carcinoma

Interventions: Drug: FMISO

First Posted Date: 2017-10-06

Last Posted Date: 2021-02-21

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 3

Registration Number: NCT03303469

Locations: 🇺🇸
UAB Advanced Imaging Facility, Birmingham, Alabama, United States

REduCing Immunogenicity to PegloticasE (RECIPE) Study

Phase 2

Completed

Conditions: Gout Chronic

Interventions: Drug: Placebo
Drug: Pegloticase 8 MG/ML [Krystexxa]
Drug: MMF

First Posted Date: 2017-10-06

Last Posted Date: 2022-03-16

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 35

Registration Number: NCT03303989

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension

Phase 2

Active, not recruiting

Conditions: Sedentary Lifestyle
Aging
Hypertension

Interventions: Behavioral: Aerobic exercise
Drug: Perindopril
Drug: Losartan
Drug: HCTZ

First Posted Date: 2017-09-28

Last Posted Date: 2024-05-08

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 213

Registration Number: NCT03295734

Locations: 🇺🇸
UAB Center for Exercise Medicine, Birmingham, Alabama, United States
🇺🇸
Translational Research Institute, Orlando, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy